Part II. Eosinophilia-Myalgia Syndrome: further correlations between compromised histamine degradation, eosinophilias and myopathies.
Smith
M J
MJ
Division of Natural Products, Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5100 Paint Branch Parkway, College Park, Maryland 20740-3835, USA. mitchell.smith@cfsan.fda.gov
Garrett
R H
RH
D004802:Eosinophilia / Q000276:immunology*; D016603:Eosinophilia-Myalgia Syndrome / Q000276:immunology*; D006632:Histamine / Q000378:metabolism*; D006801:Humans; D009135:Muscular Diseases / Q000276:immunology*